Loading...

Loading...

International Aid, Aid in Dying, AI Bias: The Week in Health
By Sofía Garduño - Thu, 03/21/2024 - 09:49
Mexico aids burn victims in the Dominican Republic; Macron introduces end-of-life legislation, and the UK tackles biases in medical devices.
https://mexicobusiness.news/tag/pfizer
More Health
Pfizer's Study Marks Milestone in DLBCL Treatment
By MBN Staff - Tue, 03/19/2024 - 10:31
Pfizer's study shows ADCETRIS combination therapy improves survival in diffuse large B-cell lymphoma patients, offering hope for better treatment.
Mexico’s Battle Against AMR Yields Results
By Sofía Garduño - Tue, 02/13/2024 - 13:38
Mexico's efforts to combat antimicrobial resistance (AMR) have successfully reduced the lethality rate from 6.71% in 2021 to 4.7% in 2023.
COFEPRIS Greenlights Moderna's Spikevax Monovalent Vaccine
By Anmol Motwani - Tue, 10/31/2023 - 17:54

Mexico’s COFEPRIS health authority approved Moderna's Spikevax Monovalent vaccine, clearing the path for its commercial distribution.

Vaccination Triumphs, Health Reforms, Personalized Cancer Care
By Anmol Motwani - Thu, 10/26/2023 - 15:58
COFEPRIS greenlights Pfizer vaccine, Senate supports reforms and ISSSTE expands its facilities. This is the Week in Health!

COFEPRIS Approves Pfizer Vaccine, Explores Other Options
By Anmol Motwani - Tue, 10/24/2023 - 10:02
COFEPRIS approves Pfizer's COVID-19 vaccine for widespread use and explores additional vaccine options for comprehensive protection.
 EHR, Omicron-Targeted Vaccine: This Week in Health
By Anmol Motwani - Thu, 09/14/2023 - 17:48
This week in health: EHR standards, tech-driven safety, an Omicron-targeted vaccine and the decriminalization of abortion.
 Biopharmaceuticals Respond to EG.5 Subvariant
By Anmol Motwani - Wed, 08/23/2023 - 16:17

Amidst surging COVID infections, key vaccine producers are rapidly refining their formulations to effectively tackle the emerging subvariant.
Primary Care, Well-being in Focus: The Week in Health
By Sofía Garduño - Thu, 07/27/2023 - 10:00
This week, CONASAMA promoted self-care while PAHO highlighted the importance of primary care in achieving universal healthcare coverage.
Johnson & Johnson Becomes Most Valuable Pharma Brand of 2023
By Sofía Garduño - Thu, 07/20/2023 - 11:52
Brand Finance's healthcare report names Johnson & Johnson as the most valuable brand worldwide.